Medivation (Drug Discovery) Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 628

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $14.3B

  • Investors
  • 3

Medivation (Drug Discovery) General Information

Description

Operator of a biopharmaceutical company focused on the development and commercialization of medically innovative therapies. The company develops novel, small molecule drugs to treat serious diseases for which there are limited treatment options, thereby offering hope to critically ill patients and their families.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 525 Market Street
  • 36th Floor
  • San Francisco, CA 94105
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • 525 Market Street
  • 36th Floor
  • San Francisco, CA 94105
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medivation (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 28-Sep-2016 $14.3B Completed Profitable
9. 2PO 28-May-2009 Completed Generating Revenue
8. PIPE 01-Jan-2008 Completed Generating Revenue
7. PIPE 10-Sep-2007 Completed Generating Revenue
6. PIPE 15-May-2006 Completed Generating Revenue
5. PIPE 01-Jan-2006 Completed Generating Revenue
4. 2PO 15-Dec-2005 Completed Clinical Trials - Phase 2
3. PIPE 17-Dec-2004 Completed Generating Revenue
2. Reverse Merger 17-Dec-2004 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Medivation (Drug Discovery)’s complete valuation and funding history, request access »

Medivation (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company focused on the development and commercialization of medically innovative therapi
Drug Discovery
San Francisco, CA
628 As of 2015

Tokyo, Japan
 

Tampa, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medivation (Drug Discovery) Competitors (61)

One of Medivation (Drug Discovery)’s 61 competitors is Astellas Pharma, a Corporation company based in Tokyo, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Astellas Pharma Corporation Tokyo, Japan
Pacira BioSciences Formerly VC-backed Tampa, FL
Sumitomo Pharma (Pharmaceuticals) Corporation Mississauga, Canada
Melinta Therapeutics Private Equity-Backed Parsippany, NJ
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 61 competitors. Get the full list »

Medivation (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medivation (Drug Discovery) Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
BB Biotech Asset Manager Minority
Crown Predator Holdings Family Office Minority
Kearny Venture Partners Venture Capital Minority
Venrock Venture Capital Minority
To view Medivation (Drug Discovery)’s complete investors history, request access »

Medivation (Drug Discovery) Investments & Acquisitions (5)

Medivation (Drug Discovery)’s most recent deal was a Corporate Asset Purchase with BioMarin (Phase III PARP) for . The deal was made on 24-Aug-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BioMarin (Phase III PARP) 24-Aug-2015 Corporate Asset Purchase Buildings and Property
Auransa 22-Dec-2014 Seed Round Discovery Tools (Healthcare)
CureTech (Pidilizumab Drug) 23-Oct-2014 Corporate Asset Purchase Buildings and Property
Orion Acquisition Corp. II 17-Dec-2004 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
609 Silver Street Corporate Asset Purchase Buildings and Property
To view Medivation (Drug Discovery)’s complete investments and acquisitions history, request access »

Medivation (Drug Discovery) ESG

Risk Overview

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Medivation (Drug Discovery)’s complete esg history, request access »

Medivation (Drug Discovery) FAQs

  • Where is Medivation (Drug Discovery) headquartered?

    Medivation (Drug Discovery) is headquartered in San Francisco, CA.

  • What is the size of Medivation (Drug Discovery)?

    Medivation (Drug Discovery) has 628 total employees.

  • What industry is Medivation (Drug Discovery) in?

    Medivation (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Medivation (Drug Discovery) a private or public company?

    Medivation (Drug Discovery) is a Private company.

  • What is the current valuation of Medivation (Drug Discovery)?

    The current valuation of Medivation (Drug Discovery) is .

  • What is Medivation (Drug Discovery)’s current revenue?

    The current revenue for Medivation (Drug Discovery) is .

  • How much funding has Medivation (Drug Discovery) raised over time?

    Medivation (Drug Discovery) has raised $161M.

  • Who are Medivation (Drug Discovery)’s investors?

    BB Biotech, Crown Predator Holdings, Kearny Venture Partners, and Venrock have invested in Medivation (Drug Discovery).

  • Who are Medivation (Drug Discovery)’s competitors?

    Astellas Pharma, Pacira BioSciences, Sumitomo Pharma (Pharmaceuticals), Melinta Therapeutics, and Genentech are some of the 61 competitors of Medivation (Drug Discovery).

  • When was Medivation (Drug Discovery) acquired?

    Medivation (Drug Discovery) was acquired on 28-Sep-2016.

  • Who acquired Medivation (Drug Discovery)?

    Medivation (Drug Discovery) was acquired by Pfizer.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process